Reducing ischaemia/reperfusion injury through δ-opioid-regulated intrinsic cardiac adrenergic cells: Adrenopeptidergic co-signalling

Cardiovascular Research

Volumn 84, Issue 3, 2009, Pages 452-460

  Huang, Ming He ^a   Nguyen, Vincent ^a   Wu, Yewen ^a   Rastogi, Saurabh ^a   Lui, Charles Y ^a   Birnbaum, Yochai ^a   Wang, Hui Qun ^b   Ware, David L ^a   Chauhan, Madhu ^a   Garg, Nisha ^a   Poh, Kian Keong ^c   Ye, Lei ^d   Omar, Abdul Razakjr ^c   Tan, Huay Cheem ^c   Uretsky, Barry F ^a   Fujise, Kenichi ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

2 Adrenergic receptor; Apoptosis; CGRP; ICA cell; Ischaemia reperfusion

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CALCITONIN GENE RELATED PEPTIDE[8-37]; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MESSENGER RNA; NEUROHORMONE; PROTEIN KINASE B;

ADULT; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HEART DENERVATION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRINSIC CARDIAC ADRENERGIC CELL; MALE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT; RECEPTOR UPREGULATION; REOXYGENATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CELL DEATH; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENKEPHALIN, D-PENICILLAMINE (2,5)-; HEART VENTRICLES; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, OPIOID, DELTA; SIGNAL TRANSDUCTION;

EID: 70849125205     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp233     Document Type: Article

References (38)

1. Huang MH, Friend DS, Sunday ME, Singh K, Haley K, Austen KF et al. An intrinsic adrenergic system in mammalian heart. J Clin Invest 1996;98: 1298-1303.
2. Palmiter RD. New adrenergic cells stimulate heart research. Nat Med 1996;2:1194-1195.
3. Ebert SN, Thompson RP. Embryonic epinephrine synthesis in the rat heart before innervation: association with pacemaking and conduction tissue development. Circ Res 2001;88:117-124.
4. Ebert SN, Taylor DG. Catecholamines and development of cardiac pace-making: an intrinsically intimate relationship. (Review). Cardiovasc Res 2006;72:364-374.
5. Huang MH, Bahl JJ, Wu Y, Larson DL, Hu FL, Ewy GA. Neuroendocrine properties of intrinsic cardiac adrenergic cells in fetal rat heart. Am J Physiol Heart Circ Physiol 2005;288:H497-H503.
6. Huang MH, Wang HQ, Roeske WR, Birnbaum Y, Wu Y, Yang NP et al. Mediating d-opioid-initiated heart protection via the b2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell. Am J Physiol Heart Circ Physiol 2007;293:H376-H384.
7. Ebert SN, Rong Q, Boe S, Pfeifer K. Catecholamine-synthesizing cells in the embryonic mouse heart. Ann NY Acad Sci 2008;1148:317-324.
8. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. (Review). Physiol Rev 2004;84:903-934.
9. Chai W, Mehrotra S, Jan Danser AH, Schoemaker RG. The role of calcito-nin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts. Euro J Pharmacol 2006;531:246-253.
10. Wolfrum S, Nienstedt J, Heidbreder M, Schneider K, Dominiak P, Dendorfer A. Calcitonin gene-related peptide mediates cardioprotection by remote preconditioning. Regul Pept 2005;127:217-224.
11. Dong YL, Chauhan M, Green KE, Vegiraju S, Wang HQ, Hankins GD et al. Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies. Am J Obstetrics Gynecol 2006;195:1657-1667.
12. Symes AJ, Rao MS, Lewis SE, Landis SC, Hyman SE, Fink JS. Ciliary neuro-trophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line. Proc Natl Acad Sci USA 1993;90:572-576.
13. Minisi AJ, Cersley TL. Vagal cardiopulmonary reflexes after left ventricular deafferentation. Circulation 1994;90:2015-2021.
14. Neely BH, Hageman GR. Effects of deafferentation or sequential occlusions on cardiac sympathetic activity during ischemia. Am J Physiol Heart Circ Physiol 1990;258:H1542-H1549.
15. Akita Y, Otani H, Matsuhisa S, Kyoi S, Enoki C, Hattori R et al. Exercise-induced activation of cardiac sympathetic nerve triggers cardi-oprotection via redox-sensitive activation of eNOS and upregulation of iNOS. Am J Physiol Heart Circ Physiol 2007;292:H2051-H2059.
16. Ye Y, Lin Y, Atar S, Huang M-H, Perez-Polo JR, Uretsky BF et al. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. Am J Physiol Heart Circ Physiol 2006;291: H1158-H1169.
17. Chow LT, Chow SS, Anderson RH, Gosling JA. Innervation of the human cardiac conduction system at birth. Br Heart J 1993;69:430-435.
18. Crick SJ, Wharton J, Sheppard MN, Royston D, Yacoub MH, Anderson RH et al. Innervation of the human cardiac conduction system. A quantitative immunohistochemical and histochemical study. Circulation 1994;89: 1697-1708.
19. Wharton J, Polak JM, Gordon L, Banner NR, Springall DR, Rose M et al. Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res 1990;66:900-912.
20. Huang MH, Knight PR III, Izzo JL. Ca2θ-dependent Ca2θ-mobilization involved in CGRP-mediated positive inotropic effect in ventricular myo-cytes. Am J Physiol Heart Circ Physiol 1999;276:R259-R264.
21. Odley A, Hahn HS, Lynch RA, Marreez Y, Osinska H, Robbins J et al. Regulation of cardiac contractility by Rab4-modulated b2-adrenergic receptor recycling. Proc Natl Acad Sci USA 2004;101:7082-7087.
22. Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ et al. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996;271:11325-11329.
23. Mieno S, Horimoto H, Sawa Y, Watanabe F, Furuya E, Horimoto S et al. Activation of b2-adrenergic receptor plays a pivotal role in generating the protective effect of ischemic preconditioning in rat hearts. Scand Cardiovasc J 2005;39:313-319.
24. Schultz JE, Hsu AK, Gross GJ. Ischemic preconditioning in the intact rat heart is mediated by delta1-but not mu-or kappa-opioid receptors. Circulation 1998;97:1282-1289.
25. Deo SH, Berlow MA, Gonzalez L, Yoshishige D, Caffrey JL. Cholinergic location of d-opioid receptors in canine atria and SA node. Am J Physiol Heart Circ Physiol 2008;294:H829-H838.
26. Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao RP. Dual modulation of cell survival and cell death by b2-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 2001;98: 1607-1612.
27. Patel HH, Head BP, Petersen HN, Niesman IR, Huang D, Gross GJ et al. Protection of adult cardiac myocytes from ischemic cell death: role of caveolar microdomains and opioid receptors. Am J Physiol Heart Circ Physiol 2006;291:H344-H350.
28. Zhou YY, Cheng H, Bogdanov KY, Hohl C, Altschuld R, Lakatta EG et al. Localized cAMP-dependent signaling mediates b2-adrenergic modulation of cardiac excitation-contraction coupling. Am J Physiol Heart Circ Physiol 1997;273:H1611-H1618.
29. Huang MH, Nguyen V, Rastogi S, Wu Y, Birnbaum Y, Lin Y et al. Post-ischemic therapy with calcitonin gene-related peptide and b2-adrenergic receptor agonist confers synergistic infarct size reduction. (Abstract). Circ Res 2007;101:1210.
30. Sanada S, Asanuma H, Tsukamoto O, Minamino T, Node K, Takashima S. Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation 2004;110:51-57.
31. Morisco C, Condorelli G, Trimarco V, Bellis A, Marrone C, Sadoshima J et al. Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res 2005;96:180-188.
32. Baines CP, Molkentin JD. TRESS signaling pathways that modulate cardiac myocyte apoptosis. (Review). J Mol Cell Cardiol 2005;38:47-62.
33. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. (Review). Cardiovasc Res 2004;61:448-460.
34. Cohen MV, Philipp S, Krieg T, Cui L, Kuno A, Solodushko V et al. Preconditioning-mimetics bradykinin and DADLE activate PI3-kinase through divergent pathways. J Mol Cell Cardiol 2007;42:842-851.
35. Krijnen PA, Nijmeijer R, Meijer CJ, Visser CA, Hack CE et al. Apoptosis in myocardial ischemia and infarction. (Review). J Clin Path 2002;55: 801-811.
36. Saetrum OO, Hasbak P, de Vries R, Saxena PR, Edvinsson L. Positive ino-tropy mediated via CGRP receptors in isolated human myocardial trabe-culae. Eur J Pharmaco 2000;397:373-382.
37. Fang X, Tang W, Sun S, Huang L, Huang Z, Weil MH. Mechanism by which activation of delta-opioid receptor reduces the severity of postresuscita-tion myocardial dysfunction. Crit Care Med 2006;34:2607-2612.
38. Goncalvesova E, Krizanova O, Micutkova L, Mravec B, Ksinantova L, Fabian J et al. Phenylethanolamine N-methyltransferase gene expression in transplanted human heart. Transplant Proc 2005;37:1340-1342.